Grassi Guido, Seravalle Gino, Quarti-Trevano Fosca, Scopelliti Francesco, Dell'Oro Raffaella, Bolla Gianbattista, Mancia Giuseppe
Clinica Medica, Dipartimento di Medicina Clinica, Prevenzione e Biotecnologie Sanitarie, Università Milano-Bicocca, Ospedale San Gerardo, Milan, Italy.
Hypertension. 2007 Mar;49(3):535-41. doi: 10.1161/01.HYP.0000255983.32896.b9. Epub 2007 Jan 8.
Congestive heart failure is characterized by sympathetic activation, which has also been described in the metabolic syndrome. No information exists, however, as to whether the sympathostimulating effects of these 2 conditions summate when heart failure is complicated by the metabolic syndrome, leading to an exceedingly high adrenergic drive. This is clinically relevant, because in heart failure sympathetic activation is closely related to mortality. We studied 48 control subjects (age: 58.4+/-1.6 years, mean+/-SEM) and 89 age-matched heart failure patients (New York Heart Association class II), of whom 47 were without and 42 were with metabolic syndrome. Measurements included blood pressure (Finapres), heart rate (ECG), and sympathetic nerve traffic (microneurography) at rest and during baroreceptor manipulation. Waist circumference, blood pressure, and metabolic variables were greater in heart failure with metabolic syndrome than in heart failure without metabolic syndrome and in control subjects. Left ventricular ejection fraction and end-diastolic diameter were similarly altered in the 2 heart failure groups. Compared with control subjects, sympathetic nerve activity was greater in heart failure patients without metabolic syndrome (64.7+/-3.2 versus 45.8+/-2.9 bursts/100 heartbeats; P<0.01), a further pronounced increase being detected in those with metabolic syndrome (80.9+/-3.2 bursts/100 heartbeats; P<0.01). In the multivariate analysis, waist circumference and body mass index were the variables most closely related to sympathetic activation. Compared with control subjects, baroreflex responses were significantly attenuated in the 2 heart failure groups, the impairment being more marked in the group with than without metabolic syndrome. Thus, obesity and metabolic syndrome potentiate the sympathetic activation characterizing heart failure. This potentiation is likely to mainly depend on metabolic and baroreflex mechanisms.
充血性心力衰竭的特征是交感神经激活,代谢综合征中也有此现象。然而,尚无关于当心力衰竭合并代谢综合征时这两种情况的交感神经刺激作用是否会叠加,从而导致肾上腺素能驱动极高的信息。这在临床上具有相关性,因为在心力衰竭中交感神经激活与死亡率密切相关。我们研究了48名对照受试者(年龄:58.4±1.6岁,平均值±标准误)和89名年龄匹配的心力衰竭患者(纽约心脏协会II级),其中47名无代谢综合征,42名有代谢综合征。测量指标包括静息时及压力感受器操作期间的血压(Finapres)、心率(心电图)和交感神经活动(微神经ography)。合并代谢综合征的心力衰竭患者的腰围、血压和代谢变量高于无代谢综合征的心力衰竭患者及对照受试者。两组心力衰竭患者的左心室射血分数和舒张末期直径有相似改变。与对照受试者相比,无代谢综合征的心力衰竭患者交感神经活动更强(64.7±3.2次/100次心跳对45.8±2.9次/100次心跳;P<0.01),有代谢综合征的患者交感神经活动进一步显著增加(80.9±3.2次/100次心跳;P<0.01)。多变量分析中,腰围和体重指数是与交感神经激活最密切相关的变量。与对照受试者相比,两组心力衰竭患者的压力反射反应均显著减弱,合并代谢综合征组的损害比无代谢综合征组更明显。因此,肥胖和代谢综合征增强了心力衰竭所特有的交感神经激活。这种增强可能主要取决于代谢和压力反射机制。